|
Volumn 27, Issue 12, 2002, Pages 1181-1194
|
Respiratory drug development compendium 2002
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
'AIR';
AD 313;
ADENOSINE A2 RECEPTOR AGONIST;
AERODOSE;
ALPHA 1 ANTITRYPSIN;
ALS 886;
ANDOLAST;
ANTIHISTAMINIC AGENT;
AVAC;
AVE 0547;
BERTILIMUMAB;
BIIL 284;
BILASTINE;
BIMOSIAMOSE;
BUDESONIDE PLUS FORMOTEROL;
CAT PAD;
CETIRIZINE;
CICLESONIDE;
COLD FX;
CS 003;
DACLIZUMAB;
DCF 987;
DENUFOSOL;
DESLORATADINE;
DISKUS;
DURAMYCIN;
DX 890;
E 4931;
EFLETERIZINE;
EPI 2010;
ETX 100;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
FUDOSTEINE;
GW 328267;
GW 559090;
HL 10;
IB 367;
ICE;
IMMUNOGLOBULIN E ANTIBODY;
INDACATEROL;
IPL 512602;
IPL 550260;
IPL 576092;
ISS 1018;
KCO 912;
KW 4490;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LEVOCETIRIZINE;
LORATADINE;
LUCINACTANT;
LUMILIXIMAB;
LUSUPULTIDE;
MBD 811;
MCC 847;
ME 3301;
MEN 91507;
MEPOLIZUMAB;
ML 03;
MONTELUKAST;
MSI;
N (3,5 DICHLORO 4 PYRIDYL) [1 (4 FLUOROBENZYL) 5 HYDROXY 3 INDOLYL]GLYOXYLIC ACID AMIDE;
NCX 950;
NORASTEMIZOLE;
NS 126;
OLOPATADINE;
OMALIZUMAB;
ONO 6126;
P 113D;
PHOSPHODIESTERASE IV INHIBITOR;
PRASTERONE SULFATE;
R 112;
RBX 7796;
RECOMBINANT GAMMA INTERFERON;
RESPIRATORY TRACT AGENT;
RUPATADINE;
S 3013;
S 5751;
S [2 (1 IMINOETHYLAMINO)ETHYL]HOMOCYSTEINE;
SB 240683;
SRP 299;
TAK 427;
TALNETANT;
TALNIFLUMATE;
TECASTEMIZOLE;
TETOMILAST;
TH 9507;
TIOTROPIUM BROMIDE;
TR 14035;
TRK 851;
UCB 35440;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
YNS 37217;
ZALTOPROFEN;
ZD 4407;
ADULT RESPIRATORY DISTRESS SYNDROME;
ALLERGIC RHINITIS;
ASTHMA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
COUGHING;
CYSTIC FIBROSIS;
DRUG INFORMATION;
HUMAN;
LUNG EMPHYSEMA;
PUBLICATION;
RESPIRATORY TRACT DISEASE;
REVIEW;
SARCOIDOSIS;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
TURBUHALER;
WASTING SYNDROME;
|
EID: 0036998750
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|